Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Mark McMillan, Helen S Marshall & Peter Richmond. (2022) 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines 21:1, pages 103-114.
Read now
Read now
Peter T. Beernink. (2020) Effect of complement Factor H on antibody repertoire and protection elicited by meningococcal capsular group B vaccines containing Factor H binding protein. Human Vaccines & Immunotherapeutics 16:3, pages 703-712.
Read now
Read now
Jamie Findlow. (2016) Vaccines for the prevention of meningococcal capsular group B disease: What have we recently learned?. Human Vaccines & Immunotherapeutics 12:1, pages 235-238.
Read now
Read now
Roberto Gasparini, Daniela Amicizia, Alexander Domnich, Piero Luigi Lai & Donatella Panatto. (2014)
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. Expert Review of Vaccines 13:3, pages 345-364.
Read now
Read now
Patricia Kaaijk, Arie van der Ende & Willem Luytjes. (2014) Routine vaccination against MenB. Human Vaccines & Immunotherapeutics 10:2, pages 310-316.
Read now
Read now
Jamie Findlow. (2013) Meningococcal group B vaccines. Human Vaccines & Immunotherapeutics 9:6, pages 1387-1388.
Read now
Read now
Seon Hee Shin & Kwang Sik Kim. (2012) Treatment of bacterial meningitis: an update. Expert Opinion on Pharmacotherapy 13:15, pages 2189-2206.
Read now
Read now
Lin H Chen, David R Hill & Annelies Wilder-Smith. (2011) Vaccination of travelers: how far have we come and where are we going?. Expert Review of Vaccines 10:11, pages 1609-1620.
Read now
Read now
Articles from other publishers (83)
Viktoriia Yu. Savitskaya, Nina G. Dolinnaya, Vadim V. Strekalovskikh, Elizaveta S. Peskovatskova, Viktoriia G. Snyga, Vadim S. Trefilov, Mayya V. Monakhova & Elena A. Kubareva. (2023) Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years: Vaccine Efficacy Prognosis. Medical Sciences 11:4, pages 76.
Crossref
Crossref
Leila Sadeghi, Elham Mohit, Samaneh Moallemi, Fatemeh Maghsood Ahmadi & Azam Bolhassani. (2023) Recent advances in various bio-applications of bacteria-derived outer membrane vesicles. Microbial Pathogenesis 185, pages 106440.
Crossref
Crossref
Lorenzo Croia, Giulia Boscato Sopetto, Ilaria Zanella, Elena Caproni, Assunta Gagliardi, Silvia Tamburini, Enrico König, Mattia Benedet, Gabriele Di Lascio, Riccardo Corbellari, Alberto Grandi, Michele Tomasi & Guido Grandi. (2023) Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens. Membranes 13:11, pages 882.
Crossref
Crossref
Jack Firth, Jingjing Sun, Vaques George, Jian-Dong Huang, Mona Bajaj-Elliott & Kenth Gustafsson. (2023) Bacterial outer-membrane vesicles promote Vγ9Vδ2 T cell oncolytic activity. Frontiers in Immunology 14.
Crossref
Crossref
Viola Viviani, Adele Fantoni, Sara Tomei, Sara Marchi, Enrico Luzzi, Margherita Bodini, Alessandro Muzzi, Marzia M. Giuliani, Domenico Maione, Jeremy P. Derrick, Isabel Delany, Mariagrazia Pizza, Alessia Biolchi & Erika Bartolini. (2023) OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans. npj Vaccines 8:1.
Crossref
Crossref
Edit I. Buzas. (2022) The roles of extracellular vesicles in the immune system. Nature Reviews Immunology 23:4, pages 236-250.
Crossref
Crossref
Dung T. Huynh, Wouter S. P. Jong, Manon A. H. Oudejans, H. Bart van den Berg van Saparoea, Joen Luirink & Peter van Ulsen. (2023) Heterologous Display of Chlamydia trachomatis PmpD Passenger at the Surface of Salmonella OMVs. Membranes 13:4, pages 366.
Crossref
Crossref
Parisa Moradi Pordanjani, Azam Bolhassani, Alireza Milani & Mohammad Hassan Pouriayevali. (2023) Extracellular vesicles in vaccine development and therapeutic approaches for viral diseases. Process Biochemistry.
Crossref
Crossref
Muhammad Ajmal Khan, Aftab Amin, Awais Farid, Amin Ullah, Abdul Waris, Khyber Shinwari, Yaseen Hussain, Khalaf F. Alsharif, Khalid J. Alzahrani & Haroon Khan. (2022) Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines. Pharmaceutics 15:1, pages 152.
Crossref
Crossref
Lesley Cheng & Andrew F. Hill. (2022) Therapeutically harnessing extracellular vesicles. Nature Reviews Drug Discovery 21:5, pages 379-399.
Crossref
Crossref
Melibea Berzosa, Alzbeta Nemeskalova, Alba Calvo, Gemma Quincoces, María Collantes, Felix Pareja, Carlos Gamazo & Juan Manuel Irache. (2022) Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate. Pharmaceutics 14:1, pages 123.
Crossref
Crossref
Jing Wang, Motao Zhu & Guangjun Nie. (2021) Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles. Advanced Drug Delivery Reviews 178, pages 113974.
Crossref
Crossref
Mina Mehanny, Claus-Michael Lehr & Gregor Fuhrmann. (2021) Extracellular vesicles as antigen carriers for novel vaccination avenues. Advanced Drug Delivery Reviews 173, pages 164-180.
Crossref
Crossref
Min Li, Han Zhou, Chen Yang, Yi Wu, Xuechang Zhou, Hang Liu & Yucai Wang. (2020) Bacterial outer membrane vesicles as a platform for biomedical applications: An update. Journal of Controlled Release 323, pages 253-268.
Crossref
Crossref
Maryam Sadat Soltani, Fereshteh Eftekhar, Fereshteh Shahcheraghi, Mojtaba Noofeli & Seyed Reza Banihashemi. (2020) Extraction of Outer membrane Vesicles from Vaccinal Strain of Bordetella Pertussis as the First Step of a Vaccine Candidate Study Against Pertussis Infection. Iranian Journal of Medical Microbiology 14:3, pages 213-226.
Crossref
Crossref
Helen S Marshall, Noel Lally, Louise Flood & Paddy Phillips. (2020) First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Medical Journal of Australia 212:2, pages 89-93.
Crossref
Crossref
Gail Whiting, Caroline Vipond, Alessandra Facchetti, Hannah Chan & Jun X. Wheeler. (2020) Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry. Vaccine 38:6, pages 1431-1435.
Crossref
Crossref
Linglei Jiang, Michelle Schinkel, Max van Essen & Raymond M. Schiffelers. (2019) Bacterial membrane vesicles as promising vaccine candidates. European Journal of Pharmaceutics and Biopharmaceutics 145, pages 1-6.
Crossref
Crossref
Tianmou Zhu, Ryan McClure, Odile B. Harrison, Caroline Genco & Paola Massari. (2019) Integrated Bioinformatic Analyses and Immune Characterization of New Neisseria gonorrhoeae Vaccine Antigens Expressed during Natural Mucosal Infection. Vaccines 7:4, pages 153.
Crossref
Crossref
Yingxuan Zhang, Zheyan Fang, Ruizhen Li, Xiaotian Huang & Qiong Liu. (2019) Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy. Cancers 11:9, pages 1314.
Crossref
Crossref
Alexandros Psarris, Michael Sindos, Georgios Daskalakis, Maria Eleni Chondrogianni, Stefani Panayiotou, Panagiotis Antsaklis & Dimitrios Loutradis. (2019) Immunizations during pregnancy: How, when and why. European Journal of Obstetrics & Gynecology and Reproductive Biology 240, pages 29-35.
Crossref
Crossref
Philip S. Watson, Patricia L. Novy & Leonard R. Friedland. (2019) Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease. International Journal of Infectious Diseases 85, pages 22-27.
Crossref
Crossref
A L Carvalho, A Miquel-Clopés, U Wegmann, E Jones, R Stentz, A Telatin, N J Walker, W A Butcher, P J Brown, S Holmes, M J Dennis, E D Williamson, S G P Funnell, M Stock & S R Carding. (2019) Use of bioengineered human commensal gut bacteria-derived microvesicles for mucosal plague vaccine delivery and immunization. Clinical & Experimental Immunology 196:3, pages 287-304.
Crossref
Crossref
Julie Côté-Gravel & François Malouin. (2019) Symposium review: Features of Staphylococcus aureus mastitis pathogenesis that guide vaccine development strategies. Journal of Dairy Science 102:5, pages 4727-4740.
Crossref
Crossref
T. Tenenbaum, W. Hellenbrand & H. Schroten. (2019) Impfstoffe gegen Meningokokken für das KindesalterVaccines against meningococci for children. Monatsschrift Kinderheilkunde 167:3, pages 196-205.
Crossref
Crossref
Jian Ma, Yunpeng Wang, Nuo Xu, Libo Jin, Jia Liu, Shaochen Xing & Xiaokun Li. (2018) Potential large scale production of meningococcal vaccines by stable overexpression of fHbp in the rice seeds. Protein Expression and Purification 152, pages 1-6.
Crossref
Crossref
Cinzia Colombo, Olimpia Pitirollo & Luigi Lay. (2018) Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development. Molecules 23:7, pages 1712.
Crossref
Crossref
Jizhen Yuan, Jie Yang, Zhen Hu, Yi Yang, Weilong Shang, Qiwen Hu, Ying Zheng, Huagang Peng, Xiaopeng Zhang, Xinyu Cai, Junmin Zhu, Ming Li, Xiaomei Hu, Renjie Zhou & Xiancai Rao. (2018) Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections. Nano Letters 18:2, pages 725-733.
Crossref
Crossref
Archana Chatterjee & Maya Gogoi. 2018. Update in Pediatrics. Update in Pediatrics
349
368
.
Jay Lucidarme, Aiswarya Lekshmi, Sydel R. Parikh, James E. Bray, Dorothea M. Hill, Holly B. Bratcher, Steve J. Gray, Anthony D. Carr, Keith A. Jolley, Jamie Findlow, Helen Campbell, Shamez N. Ladhani, Mary E. Ramsay, Martin C.J. Maiden & Ray Borrow. (2017) Frequent capsule switching in ‘ultra-virulent’ meningococci – Are we ready for a serogroup B ST-11 complex outbreak?. Journal of Infection 75:2, pages 95-103.
Crossref
Crossref
Yadira Pastor, Ana Camacho, Ana Gloria Gil, Rocío Ramos, Adela López de Ceráin, Iván Peñuelas, Juan M. Irache & Carlos Gamazo. (2017) Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine. Journal of Medical Microbiology 66:7, pages 946-958.
Crossref
Crossref
Jamie Findlow & Ray Borrow. (2017) Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?. Pathogens and Disease 75:2.
Crossref
Crossref
Susana Hernando Real, Silvia Vega Castaño & Rafael Pajares García. (2017) Meningococcemia in vaccinated patient under treatment with eculizumab. Enfermedades infecciosas y microbiologia clinica (English ed.) 35:3, pages 200-201.
Crossref
Crossref
Susana Hernando Real, Silvia Vega Castaño & Rafael Pajares García. (2017) Infección meningocócica en paciente vacunado y en tratamiento con eculizumab. Enfermedades Infecciosas y Microbiología Clínica 35:3, pages 200-201.
Crossref
Crossref
Joanna Jadwiga Klim & Renata Godlewska. (2017) Application of the bacterial outer membrane vesicles in vaccine design. Postępy Mikrobiologii - Advancements of Microbiology 56:1, pages 43-55.
Crossref
Crossref
Gro Tunheim, Marianne Arnemo, Lisbeth M. Naess, Gunnstein Norheim, Luis Garcia, Daniel Cardoso, Aleida Mandiarote, Domingo Gonzalez, Kalpana Sinnadurai, Åse-Karine Fjeldheim, Karin Bolstad & Einar Rosenqvist. (2016) Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains. APMIS 124:11, pages 996-1003.
Crossref
Crossref
Luna S. Joffe, Leonardo Nimrichter, Marcio L. Rodrigues & Maurizio Del Poeta. (2016) Potential Roles of Fungal Extracellular Vesicles during Infection. mSphere 1:4.
Crossref
Crossref
Federica Acampora Alberto Maria Marzaioli, Antonella CapuozzoMarie-Sousai Appavou, Antonella Campanella, Gerardino D'Errico Carlo IraceDaniela Montesarchio, Domenica Musumeci, Noemi Kinga Szekely, Rita SantamariaCristina De Castro & Luigi Paduano . (2016) Lipooligosaccharides as Amphiphiles to Build Liposomes for Effective Drug Delivery: The Case of Anticancer Ruthenium Complex-Based Aggregates. ChemistrySelect 1:10, pages 2129-2139.
Crossref
Crossref
Helen Marshall, Bing Wang, Steve Wesselingh, Matthew Snape & Andrew J. Pollard. (2016) Control of invasive meningococcal disease. International Journal of Evidence-Based Healthcare 14:1, pages 3-14.
Crossref
Crossref
Weiwei Huang, Yufeng Yao, Shijie Wang, Ye Xia, Xu Yang, Qiong Long, Wenjia Sun, Cunbao Liu, Yang Li, Xiaojie Chu, Hongmei Bai, Yueting Yao & Yanbing Ma. (2016) Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Scientific Reports 6:1.
Crossref
Crossref
H.S. Marshall, G. Chen, M. Clarke & J. Ratcliffe. (2016) Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment. Vaccine 34:5, pages 671-677.
Crossref
Crossref
Jamie Findlow, Xilian Bai, Helen Findlow, Emma Newton, Ed Kaczmarski, Elizabeth Miller & Ray Borrow. (2015) Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers. Vaccine 33:29, pages 3322-3330.
Crossref
Crossref
Duccio Medini, Maria Stella & James Wassil. (2015) MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Vaccine 33:23, pages 2629-2636.
Crossref
Crossref
Irene Rivero Calle, Carmen Rodriguez-Tenreiro Sánchez & Federico Martinón-Torres. (2015) Vacunas antimeningocócicas. Situación epidemiológica mundial y estrategias de prevención mediante la vacunación. Enfermedades Infecciosas y Microbiología Clínica 33:4, pages 257-267.
Crossref
Crossref
Colin P Churchward, Rubén S Rosales, Adriana Gielbert, Mercedes Domínguez, Robin A J Nicholas & Roger D Ayling. (2015)
Immunoproteomic characterisation of
M
ycoplasma mycoides
subspecies
capri
by mass spectrometry analysis of two-dimensional electrophoresis spots and western blot
. Journal of Pharmacy and Pharmacology 67:3, pages 364-371.
Crossref
Crossref
A. I. Heinson, C. H. Woelk & M.-L. Newell. (2015) The promise of reverse vaccinology. International Health 7:2, pages 85-89.
Crossref
Crossref
David M. Vickers, Andrea M. Anonychuk, Philippe De Wals, Nadia Demarteau & Chris T. Bauch. (2015) Evaluation of serogroup C and ACWY meningococcal vaccine programs: Projected impact on disease burden according to a stochastic two-strain dynamic model. Vaccine 33:1, pages 268-275.
Crossref
Crossref
Shamez N. Ladhani, Rebecca Cordery, Sema Mandal, Hannah Christensen, Helen Campbell, Ray Borrow & Mary E. Ramsay. (2014) Preventing secondary cases of invasive meningococcal capsular group B (MenB) disease using a recently-licensed, multi-component, protein-based vaccine (Bexsero®). Journal of Infection 69:5, pages 470-480.
Crossref
Crossref
María José Cilleruelo Ortega & Roi Piñeiro Pérez. (2014) Vacunación frente al meningococo B. Anales de Pediatría Continuada 12:5, pages 260-263.
Crossref
Crossref
Markus Knuf. (2014) Weitreichende Möglichkeiten der Impfprävention. Pädiatrie 26:S1, pages 20-27.
Crossref
Crossref
C. U. Koser, L. J. Fraser, A. Ioannou, J. Becq, M. J. Ellington, M. T. G. Holden, S. Reuter, M. E. Torok, S. D. Bentley, J. Parkhill, N. A. Gormley, G. P. Smith & S. J. Peacock. (2013) Rapid single-colony whole-genome sequencing of bacterial pathogens. Journal of Antimicrobial Chemotherapy 69:5, pages 1275-1281.
Crossref
Crossref
Johan Holst, Maurizio Comanducci, Stefania Bambini, Alessandro Muzzi, Sara Comandi, Jan Oksnes, Lisa DeTora, Mariagrazia Pizza, Rino Rappuoli & Dominique A. Caugant. (2014) Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway. Vaccine 32:23, pages 2722-2731.
Crossref
Crossref
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinón-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel & J.A. Vázquez. (2014) Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes. Anales de Pediatría 80:4, pages 259.e1-259.e23.
Crossref
Crossref
Stijn van der Veen, Steven Johnson, Ilse Jongerius, Talat Malik, Alessia Genovese, Laura Santini, David Staunton, Rafael L. Ufret-Vincenty, Matthew C. Pickering, Susan M. Lea & Christoph M. Tang. (2014) Nonfunctional Variant 3 Factor H Binding Proteins as Meningococcal Vaccine Candidates. Infection and Immunity 82:3, pages 1157-1163.
Crossref
Crossref
Chiara Tani, Maria Stella, Danilo Donnarumma, Massimiliano Biagini, Pierino Parente, Alessandro Vadi, Claudia Magagnoli, Paolo Costantino, Fabio Rigat & Nathalie Norais. (2014) Quantification by LC–MSE of outer membrane vesicle proteins of the Bexsero® vaccine. Vaccine 32:11, pages 1273-1279.
Crossref
Crossref
Stephen A. Clark, Jay Lucidarme, Lynne S. Newbold & Ray Borrow. (2014) Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens. PLoS ONE 9:2, pages e89921.
Crossref
Crossref
X. SUN, H. ZHOU, L. XU, H. YANG, Y. GAO, B. ZHU & Z. SHAO. (2013)
Prevalence and genetic diversity of two adhesion-related genes,
pilE
and
nadA
, in
Neisseria meningitidis
in China
. Epidemiology and Infection 141:10, pages 2163-2172.
Crossref
Crossref
Alexandra Schubert-Unkmeir & Myron Christodoulides. (2013) Genome-Based Bacterial Vaccines: Current State and Future Outlook. BioDrugs 27:5, pages 419-430.
Crossref
Crossref
Jay Lucidarme, Jamie Findlow, Hannah Chan, Ian M. Feavers, Stephen J. Gray, Edward B. Kaczmarski, Julian Parkhill, Xilian Bai, Ray Borrow & Christopher D. Bayliss. (2013) The Distribution and ‘In Vivo’ Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis. PLoS ONE 8:9, pages e76932.
Crossref
Crossref
Bas van de Waterbeemd, Gijsbert Zomer, Patricia Kaaijk, Nicole Ruiterkamp, René H. Wijffels, Germie P. J. M. van den Dobbelsteen & Leo A. van der Pol. (2013) Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis. PLoS ONE 8:5, pages e65157.
Crossref
Crossref
Stefania Bambini, Jurgen Piet, Alessandro Muzzi, Wendy Keijzers, Sara Comandi, Lisa De Tora, Mariagrazia Pizza, Rino Rappuoli, Diederik van de Beek, Arie van der Ende & Maurizio Comanducci. (2013) An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands. PLoS ONE 8:5, pages e65043.
Crossref
Crossref
Miao-Chiu Hung, John E. Heckels & Myron Christodoulides. (2013) The Adhesin Complex Protein (ACP) of Neisseria meningitidis Is a New Adhesin with Vaccine Potential. mBio 4:2.
Crossref
Crossref
Renee Phillips, Jeannette N. Williams, Wei-Ming Tan, Magdalena K. Bielecka, Hannah Thompson, Miao-Chiu Hung, John E. Heckels & Myron Christodoulides. (2013) Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis. Vaccine 31:22, pages 2584-2590.
Crossref
Crossref
Ulrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, Jamie Findlow, Heike Claus, Paola Stefanelli, Dominique A Caugant, Paula Kriz, Raquel Abad, Stefania Bambini, Anna Carannante, Ala Eddine Deghmane, Cecilia Fazio, Matthias Frosch, Giacomo Frosi, Stefanie Gilchrist, Marzia M Giuliani, Eva Hong, Morgan Ledroit, Pietro G Lovaglio, Jay Lucidarme, Martin Musilek, Alessandro Muzzi, Jan Oksnes, Fabio Rigat, Luca Orlandi, Maria Stella, Danielle Thompson, Mariagrazia Pizza, Rino Rappuoli, Davide Serruto, Maurizio Comanducci, Giuseppe Boccadifuoco, John J Donnelly, Duccio Medini & Ray Borrow. (2013) Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. The Lancet Infectious Diseases 13:5, pages 416-425.
Crossref
Crossref
Isfahan Tauseef, Youssif M. Ali & Christopher D. Bayliss. (2013) Phase Variation of PorA, a Major Outer Membrane Protein, Mediates Escape of Bactericidal Antibodies by Neisseria meningitidis. Infection and Immunity 81:4, pages 1374-1380.
Crossref
Crossref
Michael D. Nissen, Helen S. Marshall, Peter C. Richmond, Qin Jiang, Shannon L. Harris, Thomas R. Jones, Kathrin U. Jansen & John L. Perez. (2013) A Randomized, Controlled, Phase 1/2 Trial of a Neisseria meningitidis Serogroup B Bivalent rLP2086 Vaccine in Healthy Children and Adolescents. Pediatric Infectious Disease Journal 32:4, pages 364-371.
Crossref
Crossref
. (2013) Protecting university students in the UK against meningococcal disease: vaccination is the way forward. Perspectives in Public Health 133:2, pages 90-91.
Crossref
Crossref
Enrico MalitoAgnese FaleriPaola Lo SurdoDaniele VeggiGiulietta MaruggiEva GrassiElena CartocciIsabella BertoldiAlessia GenoveseLaura SantiniGiacomo RomagnoliErica BorgogniSébastien BrierCarla Lo Passo, Maria DominaFlora CastellinoFranco Felici, Stijn van der Veen, Steven Johnson, Susan M. Lea, Christoph M. Tang, Mariagrazia PizzaSilvana SavinoNathalie NoraisRino RappuoliMatthew J. BottomleyVega Masignani. (2013) Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proceedings of the National Academy of Sciences 110:9, pages 3304-3309.
Crossref
Crossref
Anna Bernardi, Jesus Jiménez-Barbero, Alessandro Casnati, Cristina De Castro, Tamis Darbre, Franck Fieschi, Jukka Finne, Horst Funken, Karl-Erich Jaeger, Martina Lahmann, Thisbe K. Lindhorst, Marco Marradi, Paul Messner, Antonio Molinaro, Paul V. Murphy, Cristina Nativi, Stefan Oscarson, Soledad Penadés, Francesco Peri, Roland J. Pieters, Olivier Renaudet, Jean-Louis Reymond, Barbara Richichi, Javier Rojo, Francesco Sansone, Christina Schäffer, W. Bruce Turnbull, Trinidad Velasco-Torrijos, Sébastien Vidal, Stéphane Vincent, Tom Wennekes, Han Zuilhof & Anne Imberty. (2013) Multivalent glycoconjugates as anti-pathogenic agents. Chem. Soc. Rev. 42:11, pages 4709-4727.
Crossref
Crossref
Ray Borrow. (2012)
Advances with vaccination against
Neisseria meningitidis
. Tropical Medicine & International Health 17:12, pages 1478-1491.
Crossref
Crossref
Daniele Veggi, Maria A. Gentile, Francesca Cantini, Paola Lo Surdo, Vincenzo Nardi-Dei, Kate L. Seib, Mariagrazia Pizza, Rino Rappuoli, Lucia Banci, Silvana Savino & Maria Scarselli. (2012)
The Factor H Binding Protein of
Neisseria meningitidis
Interacts with Xenosiderophores in Vitro
. Biochemistry 51:46, pages 9384-9393.
Crossref
Crossref
Brian D. Plikaytis, Maria Stella, Giuseppe Boccadifuoco, Lisa M. DeTora, Mauro Agnusdei, Laura Santini, Brunella Brunelli, Luca Orlandi, Isabella Simmini, Marzia Giuliani, Morgan Ledroit, Eva Hong, Muhamed-Kheir Taha, Kim Ellie, Gowrisankar Rajam, George M. Carlone, Heike Claus, Ulrich Vogel, Ray Borrow, Jamie Findlow, Stefanie Gilchrist, Paola Stefanelli, Cecilia Fazio, Anna Carannante, Jan Oksnes, Elisabeth Fritzsønn, Anne-Marie Klem, Dominique A. Caugant, Raquel Abad, Julio A. Vázquez, Rino Rappuoli, Mariagrazia Pizza, John J. Donnelly & Duccio Medini. (2012) Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational Vaccines. Clinical and Vaccine Immunology 19:10, pages 1609-1617.
Crossref
Crossref
P.C. Richmond, M.D. Nissen, H.S. Marshall, S.B. Lambert, D. Roberton, W.C. Gruber, T.R. Jones & A. Arora. (2012) A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine 30:43, pages 6163-6174.
Crossref
Crossref
M.-A. Dommergues. (2012) Les vaccins méningococciques de sérogroupe B. Archives de Pédiatrie 19, pages S65-S69.
Crossref
Crossref
Tobias Tenenbaum & Markus Knuf. (2012) Neue Impfung gegen Meningokokken B. Pädiatrie 24:4, pages 264-267.
Crossref
Crossref
James Wassil, E David G McIntosh, Davide Serruto, Lisa DeTora, Michael Bröker & Alan Kimura. (2012) The early clinical development of a multicomponent vaccine against meningococcal serogroup B. Clinical Investigation 2:5, pages 503-517.
Crossref
Crossref
Peter M. Dull & E. David McIntosh. (2012) Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease. Vaccine 30, pages B18-B25.
Crossref
Crossref
Matthew J. Bottomley, Davide Serruto, Marco Aurélio Palazzi Sáfadi & Keith P. Klugman. (2012) Future challenges in the elimination of bacterial meningitis. Vaccine 30, pages B78-B86.
Crossref
Crossref
Johan Holst, Hanne Nøkleby & Julie A. Bettinger. (2012) Considerations for controlling invasive meningococcal disease in high income countries. Vaccine 30, pages B57-B62.
Crossref
Crossref
Emmanuel Grimprel. (2012) Nouveautés vaccinales en médecine humaine. Bulletin de l'Académie Nationale de Médecine 196:3, pages 575-588.
Crossref
Crossref
Mariagrazia Pizza, Lisa DeTora & James Wassil. (2012) Advances in meningococcal vaccines. Clinical Practice 9:1, pages 101-117.
Crossref
Crossref
Veronica Esposito, Valeria Musi, Cesira de Chiara, Daniele Veggi, Davide Serruto, Maria Scarselli, Geoff Kelly, Mariagrazia Pizza & Annalisa Pastore. (2011) Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis. Journal of Biological Chemistry 286:48, pages 41767-41775.
Crossref
Crossref
Maria ScarselliBeatrice AricòBrunella BrunelliSilvana SavinoFederica Di MarcelloEmmanuelle PalumboDaniele VeggiLaura CiucchiElena CartocciMatthew James BottomleyEnrico MalitoPaola Lo SurdoMaurizio ComanducciMarzia Monica GiulianiFrancesca CantiniSara DragonettiAnnalisa ColapricoFrancesco DoroPatrizia GiannettiMichele PallaoroBarbara BrogioniMarta TontiniMarkus HilleringmannVincenzo Nardi-DeiLucia BanciMariagrazia PizzaRino Rappuoli. (2011) Rational Design of a Meningococcal Antigen Inducing Broad Protective Immunity. Science Translational Medicine 3:91.
Crossref
Crossref